CGAS and neurodegenerative disease: As mechanistic studies continue to uncover novel pathogenic mediators within the cGAS-STING-IFN-I signaling pathway, diverse drug targets will likely be explored in the years to come, offering hope for the development of effective treatments for neurodegenerative diseases.